FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Ascend Laboratories Amlodipine and Olmesartan Medoxomil Tablets Recall

Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufa…

Ascend Laboratories, LLC · Bedminster, NJ

Risk level
Class II
Reported by FDA
Jun 10, 2026
Recall ID
D-0556-2026
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Amlodipine and Olmesartan Medoxomil Tablets starting May 5, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0556-2026 on Jun 10, 2026. Reason: Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Product description

Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.

Lot numbers, UPCs & expiration codes

Lot: 24123460, Expires: October 31, 2027.

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0556-2026
Classification
Class II
Status
Ongoing
Recall initiated
May 5, 2026
FDA report date
Jun 10, 2026
Quantity
15,696 x 30's bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0556-2026, exactly as published.

Show all FDA fields
City
Bedminster
State
NJ
Status
Ongoing
Country
United States
Event ID
98874
Address
135 Us Highway 202 206 Ste 15
Code information
Lot: 24123460, Expires: October 31, 2027.
Postal code
07921-2608
Report date
Jun 10, 2026
Product type
Drugs
Recall number
D-0556-2026
Classification
Class II
Recalling firm
Ascend Laboratories, LLC
Product quantity
15,696 x 30's bottles
Reason for recall
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
Distribution pattern
U.S.A. Nationwide
Recall initiation date
May 5, 2026
Initial firm notification
Letter
Center classification date
Jun 2, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0556-2026, published Jun 10, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls